Patients who have had serious side effects from antithyroid drugs—like low white blood cell counts or liver damage—are more likely to choose surgery because they want to avoid taking any more drugs that could harm them.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether prior severe adverse reactions to antithyroid drugs consistently predict higher rates of surgery over radioactive iodine across diverse populations and whether this leads to improved long-term outcomes.
A systematic review and meta-analysis of all prospective cohort studies comparing treatment selection (surgery vs RAI) in Graves' disease patients with documented severe ATD reactions (agranulocytosis, vasculitis, hepatotoxicity) versus those without, pooling adjusted odds ratios and secondary outcomes including recurrence and quality of life.
Whether patients with Graves' disease who experience severe ATD reactions are more likely to choose surgery over time, and whether this choice reduces future adverse events.
A prospective cohort study of 800 adults with Graves' disease who experienced severe ATD reactions (agranulocytosis, liver failure, vasculitis), tracking their subsequent treatment choice (surgery vs RAI) and recording recurrence, new adverse events, and patient-reported satisfaction over 5 years.
The prevalence of prior severe ATD reactions among patients who have chosen surgery versus radioactive iodine in a real-world clinical setting.
A cross-sectional survey of 1,200 adults with Graves' disease who underwent definitive treatment, documenting prior severe ATD reactions (agranulocytosis, hepatotoxicity, vasculitis) and their association with treatment choice (surgery vs RAI).
Whether patients who chose surgery are more likely to have had severe ATD reactions than those who chose radioactive iodine, after adjusting for age and thyroid size.
A matched case-control study comparing 200 patients who underwent surgery with 200 who received RAI, matched for age and thyroid volume; cases and controls assessed for history of severe ATD reactions using medical record review and structured interviews.
Consensus among endocrinologists on whether severe ATD reactions should be considered a strong indication for surgery over radioactive iodine.
A Delphi consensus study of 40 thyroid specialists rating the strength of evidence for recommending surgery over RAI in patients with documented severe ATD reactions, using a 9-point scale with three rounds of feedback.